Recent Price Movement and Volatility
On 19 Jan 2026, Crestchem opened with an intraday gain of 8.31%, reaching a high of Rs.104.90. However, the stock reversed sharply to touch its low of Rs.93.05, closing at this 52-week trough. The intraday volatility was notably high at 5.98%, reflecting significant price swings during the trading session. This price level is substantially below the stock’s 52-week high of Rs.329, highlighting the extent of the decline over the past year.
The stock currently trades below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum. This technical positioning underscores the challenges Crestchem faces in regaining upward traction in the near term.
Comparative Market Context
While Crestchem’s stock has been under pressure, broader market indices have shown mixed trends. The Sensex opened flat but traded slightly lower by 0.22% at 83,385.92 points, remaining 3.33% below its 52-week high of 86,159.02. The index has experienced a three-week consecutive decline, losing 2.77% over this period. Notably, the Sensex is trading below its 50-day moving average, although the 50DMA remains above the 200DMA, indicating some underlying market resilience despite recent weakness.
Long-Term Performance and Financial Metrics
Over the last year, Crestchem’s stock has delivered a negative return of 65.07%, a stark contrast to the Sensex’s positive 8.83% gain during the same timeframe. This underperformance extends beyond the past year, with Crestchem lagging the BSE500 index over the last three years, one year, and three months.
Financially, the company’s operating profits have grown at a compound annual growth rate (CAGR) of 19.73% over the past five years, indicating some growth momentum. However, the ability to service debt remains constrained, with an average EBIT to interest coverage ratio of 1.75, reflecting limited buffer to meet interest obligations comfortably.
Return on Capital Employed (ROCE) for the half-year ended September 2025 stood at 32.96%, the lowest recorded in recent periods, signalling pressure on capital efficiency. Meanwhile, the Return on Equity (ROE) remains relatively strong at 25%, suggesting that shareholder returns have been maintained despite broader challenges.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Valuation and Shareholding Profile
Crestchem’s valuation metrics present a mixed picture. The stock trades at a Price to Book (P/B) ratio of 3.6, which is considered very attractive relative to its sector peers’ historical averages. This suggests that despite the recent price decline, the stock is valued fairly in comparison to its intrinsic book value.
Profitability has declined over the past year, with net profits falling by 36.3%, further contributing to the stock’s downward pressure. The majority of Crestchem’s shares are held by non-institutional investors, indicating a shareholder base that may be more susceptible to market sentiment shifts.
Sector and Industry Considerations
Operating within the Specialty Chemicals industry, Crestchem faces sector-specific dynamics that influence its performance. The sector has experienced varied performance trends, with some companies benefiting from demand shifts while others contend with pricing pressures and input cost fluctuations. Crestchem’s recent underperformance relative to its sector peers highlights the challenges it currently faces in maintaining competitive positioning.
Summary of Ratings and Scores
According to MarketsMOJO’s latest assessment dated 16 Jan 2026, Crestchem holds a Mojo Score of 31.0 and a Mojo Grade of Sell, an upgrade from its previous Strong Sell rating. The Market Cap Grade stands at 4, reflecting the company’s relative size and market capitalisation metrics. The downgrade in sentiment aligns with the stock’s recent price action and financial performance indicators.
Holding Crestchem Ltd from Specialty Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Concluding Observations
Crestchem Ltd’s stock has experienced a notable decline, culminating in a fresh 52-week low of Rs.93.05. The stock’s performance over the past year has been significantly weaker than the broader market, with key financial ratios indicating pressures on profitability and debt servicing capacity. Despite a relatively attractive valuation on a price-to-book basis and a solid ROE, the stock remains below all major moving averages and has exhibited high volatility in recent sessions.
Market conditions, including a modestly declining Sensex and sector-specific headwinds, have compounded the stock’s challenges. The company’s financial metrics and recent rating adjustments reflect a cautious stance on its near-term prospects. Investors and market participants will continue to monitor Crestchem’s performance within the context of its sector and broader market trends.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
